Influence of hepatitis C virus infection on soluble cellular adhesion molecules in hemodialysis patients

Blood Purification

Volumn 23, Issue 2, 2005, Pages 106-112

  Peng, Yu Sen ^a   Chiang, Chih Kang ^a   Hsu, Shih Ping ^a   Pai, Mei Fen ^a   Hung, Kuan Yu ^a,b   Kao, Jia Horng ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

E selectin; Hemodialysis; Hepatitis C; Soluble intercellular adhesion molecule 1; Soluble vascular cellular adhesion molecule 1

Indexed keywords

BIOLOGICAL MARKER; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEPATITIS C ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; AGE DISTRIBUTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEPATITIS C; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RNA ANALYSIS; SAMPLE SIZE;

AGED; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CROSS-SECTIONAL STUDIES; E-SELECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SOLUBILITY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 16344373476     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083204     Document Type: Article

References (30)

1. Parfrey PS: Cardiac and cerebrovascular disease in chronic uremia. Am J Kidney Dis 1993;21:77-80.
2. Gearing AJ, Newman W: Circulating adhesion molecules in disease. Immunol Today 1993;14:506-512.
3. Van der Meer IM, de Maat MP, Bots ML, Breteler MM, Meijer J, Kiliaan AJ, Hofman A, Witteman JC: Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: The Rotterdam Study. Arterioscler Thromb Vase Biol 2002;22:838-842.
4. Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, Hafner G, Tiret L, Meyer J: Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001;104:1336-1342.
5. Becker A, van Hinsbergh VW, Jager A, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD: Why is soluble intercellular adhesion molecule-1 related to cardiovascular mortality? Eur J Clin Invest 2002;32:1-8.
6. Rabb H, Calderon E, Bittle PA, Ramirez G: Alterations in soluble intercellular adhesion molecule-1 and vascular cell adhesion-1 in hemodialysis patients. Am J Kidney Dis 1996;27:239-243.
7. Jacobson SH, Egberg N, Hylander B, Lundahl J: Correlation between soluble markers of endothelial dysfunction in patients with renal failure. Am J Nephrol 2002;22:42-47.
8. Bolton CH, Downs LG, Victory JGG, Dwight JF, Tomson CRV, Mackness MI, Pinkney JH: Endothelial dysfunction in chronic renal failure: Roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 2001;16:1189-1197.
9. Stenvinkel P, Lindholm B, Heimbürger M, Heimbürger O: Elevated serum levels of soluble adhesion molecules predict death in predialysis patients: Association with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant 2000;15:1624-1630.
10. Papagianni A, Kalovoulos M, Kirmizis D, Vainas A, Belechri AM, Alexopoulos E, Memmos D: Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic hemodialysis patients. Nephrol Dial Transplant 2003;18:113-119.
11. Stenvinkel P, Wanner C, Metzger T, Heimbürger O, Mallamaci F, Tripepi G, Malatino L, Zoccali C: Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage? Kidney Int 2002;62:1791-1798.
12. Blake GJ, Ridker PM: Novel clinical markers of vascular inflammation. Circ Res 2001;89:763-771.
13. Spittle MA, Hoenich NA, Handelman GJ, Adhikarla R, Homel P, Levin NW: Oxidative stress and inflammation in hemodialysis patients. Am J Kidney Dis 2001;38:1408-1413.
14. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-658.
15. Hung KY, Chen WY, Yang CS, Lee SH, Wu DJ: Hepatitis B and C in hemodialysis patients. Dial Transplant 1995;24:135-139.
16. Hung KY, Shyu RS, Huang CH, Tsai TJ, Chen WY: Viral hepatitis in continuous ambulatory peritoneal dialysis patients in an endemic area for hepatitis B and C infection: The Taiwan experience. Blood Purif 1999;15:195-199.
17. Hung KY, Shyu RS, Tsai TJ, Chen WY: Viral hepatitis infection should be considered for evaluating uremic pruritus in continuous ambulatory peritoneal dialysis patients. Blood Purif 1998;16:147-153.
18. Hung KY, Wu DJ, Wu KD, Chen WY, Tsai TJ: Serum ferritin level required for adequate response to recombinant human erythropoietin in haemodialysis patients with hepatitis C virus infection. Nephrol Dial Transplant 1998;13:2709-2710.
19. Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ: Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 1998;32:629-634.
20. Nakayama E, Akiba T, Marumo F, Sato C: Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000;11:1896-1902.
21. Guadalupe Ercilla M, Vinas O: Extrahepatic symptoms of hepatitis C virus infection: Relation to autoimmune response. Nephrol Dial Transplant 2000;15(suppl 8):24-27.
22. Yang SS, Tsai G, Wu CH, Chen DS: Circulating soluble intercellular adhesion molecule-1 in type C viral hepatitis. Hepatitis 1996;43:575-581.
23. Fukuda Y, Nakano I, Katano Y, Marui A, Hayakawa T: Serum levels of soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in asymptomatic carriers of hepatitis C virus. J Int Med Res 1998;26:313-318.
24. Mosnier JF, Scoazec JY, Marcellin P, Degott C, Benhamou JP, Feldmann G: Expression of cytokine-dependent immune adhesion molecules by hepatocytes and bile duct cells in chronic hepatitis C. Gastroenterology 1994; 107:1457-1468.
25. Ridker PM, Hennekens CH, Buring JE, Kundsin R, Shih J: Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk of cardiovascular disease in women. Ann Intern Med 1999;131:573-577.
26. Hoofnagle JH: Course and outcome of hepatitis C. Hepatology 2002;36(suppl 1):21-29.
27. Ishizaka N, Ishizaka Y, Takahashi E, Tooda E, Hashimoto H, Nagai R, Yamakado M: Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet 2002;359:133-135.
28. Lupattelli G, Lombardini R, Schillaci G, Ciuffetti G, Marchesi S, Siepi D, Mannarino E: Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: Association with small, dense LDL cholesterol particles. Am Heart J 2000;140:521-526.
29. Sampietro T, Tuoni M, Ferdeghini M, Ciardi A, Marraccini P, Prontera C, Sassi G, Taddei M, Bionda A: Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia. Circulation 1997;96:1381-1385.
30. Noter JR, Kehrel B, Fobker M, Levkau B, Assmann G, Eckardstein A: HDL and arteriosclerosis: Beyond reverse cholesterol transport. Atherosclerosis 2002;161:1-16.